SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
COVID-19에서 회복된 사람들의 감염 1년 후 SARS-CoV-2-특이 항체 및 T-세포 반응: 종단 코호트 연구
Article
Published on
Journal: The Lancet. Microbe [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, 치료기술,
Journal: The Lancet. Microbe [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, 치료기술,
[키워드] Academy
age
analysed
antibody
Antibody Response
antibody titres
B.1.351
B.1.617.2
Beta
Beta variant
breadth
caused
center
Chinese
collected
communicable disease
Communicable Disease Diagnosis
COVID-19
Critical
cross-reactive
cytokine
cytokine profile
D614G
D614G variant
delta variant
Delta variants
detect
detectable
discharged
disease
disease severity
ELISA
ELISPOT
enrolled
enzyme
evaluated
Follow-up
Follow-up visit
follow-up visits
foundation
humoral
humoral and T-cell response
ICS
IFN-γ
IFNγ
IgA
IgG antibodies
IgG antibody
IgM
IL-2
immune
immune response
In-vitro
individual
individuals
Infection
initial
interferon
interferon γ
interleukin
interleukin-2
intracellular cytokine staining
longitudinal cohort study
magnitude
Medical Research Council
Medical Sciences
memory
memory immune response
memory T-cell response
memory T-cell responses
microneutralisation assay
natural
Necrosis
neutralising
Neutralising Antibodies
neutralising antibody
neutralising antibody response
Neutralising antibody responses
neutralising antibody titre
neutralising antibody titres
no difference
not disrupted
participant
Patient
patients
patients with moderate
PBMC
PBMCs
plasma
plasma sample
plasma samples
Protein
Receptor-binding domain
recovered patient
recovered patients
recruited
reduce
reduced
reducing
reduction
Reinfection
remained
retained
robustness
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 nucleoprotein
SARS-CoV-2 strain
SARS-CoV-2 viral
SARS-CoV-2-specific T-cell response
Science
severe disease
spike
Spike protein
subset
symptom severity
Symptoms
T-cell Response
T-cell responses
tested
the interferon
the receptor-binding domain
the SARS-CoV-2
titre
TNFα
tumour necrosis factor
Tumour Necrosis Factor α
variant
variants
variants of concern
Viral proteins
viral strain
viral strains
Wuhan
Wuhan, China
[DOI] 10.1016/S2666-5247(22)00036-2 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/S2666-5247(22)00036-2 PMC 바로가기 [Article Type] Article